Maxwell Chappell is a graduate student working on developing improved lentiviral vectors as well as the use of lentiviral vectors for the treatment of alpha-thalassemia.
A surgeon-scientist explores exosome-mediated stem cell engraftment as a means to lessen disease severity and enhance quality of life for children with hemoglobinopathies.
Pioneering new approaches to diagnosis, care, and treatment for patients with red blood cell disorders with novel gene therapies and stem-cell-based treatments that aim to reduce symptoms and prolong life.
